Model Access and Configuration for Autoimmune Pharmacovigilance

Autoimmune disease pharmacovigilance data originates from clinical trial reports, real-world evidence (RWE), physician-submitted adverse event (AE)

Data Characteristics in this Domain

Autoimmune disease pharmacovigilance data originates from clinical trial reports, real-world evidence (RWE), physician-submitted adverse event (AE) reports, patient self-reports, and medical literature. This data updates frequently, especially after new drugs launch or new adverse event reports emerge. Document structures are complex, potentially including unstructured free-text descriptions, semi-structured case report forms (CRFs), and structured laboratory test results. Beyond common demographic information and medication history, key fields include disease activity scores (e.g., SLEDAI for lupus), specific autoantibody profiles (e.g., ANA, ENA) test results, and immunosuppressant dosages and treatment durations. Units vary; for instance, laboratory indicators might use mg/dL or IU/mL, while drug dosages might use mg/kg or mg/day.

Constraints on Model Access and Configuration

The complexity of autoimmune pharmacovigilance data imposes specific requirements on model access and configuration. High-frequency data sources necessitate models that support continuous learning or regular incremental updates to prevent information obsolescence. The large volume of unstructured text, such as adverse event descriptions, requires robust natural language processing (NLP) capabilities, including medical entity recognition and symptom/adverse reaction extraction. The mix of semi-structured and structured data demands flexible data parsing strategies to ensure effective integration of all information. Accurate identification and standardization of critical fields like specific autoantibodies and disease activity scores are central, requiring effective unit conversion and synonym handling during preprocessing. Furthermore, adverse event reports can be ambiguous or subjective. Models must configure appropriate confidence thresholds when generating risk signals to balance recall and precision.

Configuration Guidelines

Configuration ItemRecommended ValueRationale
Chunk size (Chunk Size)500–800 charactersBalances semantic completeness with model processing efficiency, preventing key information dilution in overly long texts.
Recall count (Recall Count)8–12 itemsAutoimmune adverse event reports can have weaker associations; increasing recall appropriately improves coverage.
Similarity threshold (Similarity Threshold)0.75–0.85Autoimmune diseases manifest diversely, requiring a higher similarity threshold for precise matching.
Rerank result count (Reranked Return Count)3–5 itemsReranked models more accurately filter the most relevant few results, reducing redundancy.
PARSE_FILE_TIMEOUT_SECONDS600 secondsProcessing large clinical trial reports or multiple merged documents requires longer parsing times.
VECTOR_DIMENSION1536Compatible with mainstream embedding models (e.g., OpenAI text-embedding-ada-002), ensuring rich vector representation.

Common Pitfalls

  • Knowledge base retrieval results are empty or irrelevant: This often occurs due to insufficient synonym expansion and medical entity recognition for disease-specific terminology.
  • Model cannot search for the latest information online: This typically happens when the allow_internet_access parameter is incorrectly configured or the network proxy HTTP_PROXY settings are wrong, preventing the model from accessing external resources.
  • TimeoutError when processing large PDF documents: The file parsing process exceeded the PARSE_FILE_TIMEOUT_SECONDS limit. This may require adjusting the parameter or optimizing the document preprocessing workflow.

Verification Steps

  • Upload and parse a clinical report containing various autoimmune adverse reactions. Check if key information (e.g., drug names, adverse events, laboratory indicators) is extracted correctly.
  • Submit a query about a rare adverse reaction of a specific autoimmune drug. Verify if the knowledge base recalls relevant literature or case reports and if the recall count meets expectations.
  • Simulate a new adverse reaction report. Observe if the model generates a response with risk signal alerts, combining existing knowledge base content. Verify if the response mentions relevant autoimmune disease-specific indicators.
  • Check model logs for HTTP 200 status codes for external API calls to confirm internet access functionality.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.